AIDS AND THE HEALTH-CARE WORKER: MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN THE HEALTH-CARE SETTING NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS AND THE HEALTH-CARE WORKER: MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN THE HEALTH-CARE SETTING

AIDS Updates; 1(1):1-12 1988. Unique Identifier : AIDSLINE ICDB/89657615
Henderson DK; Hosp. Epidemiology Service, Warren Grant Magnuson Clinical; Center, NIH, Bethesda, MD


Abstract: With the discovery of the agent responsible for AIDS and the subsequent development of serologic tests for antibodies directed against HIV-1, it has become possible to assess more clearly the risk for occupational/nosocomial transmission of the virus. The seropositivity rates of health-care workers (HCWs) have been shown to be very low relative to the population at large. As of May 1988, 236 cases of AIDS in HCWs had been reported to the Centers for Disease Control as having occurred in HCWs who reported no known risk for HIV-1. Investigations completed in 124 of these cases resulted in 84 being reclassified into traditional risk-behavior categories. While 40 cases remained in the 'no identified risk' group, there are reasons to believe that some of these individuals also may have engaged in risk behaviors. In case reports of 25 occupational/nosocomial HIV-1 infections that have been published, 17 individuals who sustained injuries were followed prospectively and were shown to seroconvert later. In 10 prospective studies of HCWs exposed to body fluids (1320 HCWs are being followed who have reported 1389 percutaneous exposures to blood or other body fluids of a patient (pt) known to be infected with HIV-1), there have been 5 occupationally related seroconversions. No seroconversions have been reported in 8 longitudinal prospective studies involving 538 HCWs who reported 921 mucous membrane exposures to blood or other body fluids. A summary is presented of Universal Precautions, issued for prevention of HIV-1 infection among HCWs, that cover clothing, isolation of pts, management of equipment that may be contaminated, clean-up of blood and body fluid spills, and compliance management. Specific precautions that deserve special emphasis are discussed: management of needles and sharp objects, decontamination and sterilization, support services and waste disposal, and compliance. Areas of controversy in the prevention of HIV-1 infection among HCWs include management of employees who have sustained adverse exposures to blood or other blood-containing body fluids, management of HIV-1-infected HCWs, HIV-1 antibody testing of pts, and the right of HCWs to refuse to care for HIV-1-infected pts. (105 Refs)
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL/ *TRANSMISSION Cross Infection/PREVENTION & CONTROL/TRANSMISSION Cross-Sectional Studies *Health Occupations Human HIV Seropositivity/TRANSMISSION HIV-1/*PATHOGENICITY Longitudinal Studies Occupational Diseases/PREVENTION & CONTROL/*TRANSMISSION Prospective Studies Risk Factors JOURNAL ARTICLE REVIEW, TUTORIAL REVIEWKWDacquiredimmunodeficiencysyndrome/prevention&control/KWDtransmissioncrossinfection/prevention&control/transmissioncross-sectionalstudiesKWDhealthoccupationshumanhivseropositivity/transmissionhiv-1/KWDpathogenicitylongitudinalstudiesoccupationaldiseases/prevention&control/KWDtransmissionprospectivestudiesriskfactorsjournalarticlereview,tutorialreview
891230
M89C0823

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .